These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: A double-blind controlled trial of the effect of sodium cromoglycate in preventing relapse in ulcerative colitis.
    Author: Whorwell PJ, Whorwell GM, Bamforth J, Colin Jones D, Down P, Edwards A, Gent AE, Golding P, Gough KR, Hellier MD, Isaacson P, Loehry CA, Milton-Thompson GJ, Smith CL, Waldram RP, Wright R.
    Journal: Postgrad Med J; 1981 Jul; 57(669):436-8. PubMed ID: 6118859.
    Abstract:
    A double-blind controlled trial of the effect of sodium cromoglycate (SCG) in preventing relapse in ulcerative colitis has been completed in 100 subjects. In patients already taking sulphasalazine, SCG did not prove to be of any additional benefit. However, in patients not on any other maintenance therapy, the relapse rate was 40% for SCG as compared with 75% for placebo. A large study of the effect of SCG in patients intolerant of sulphasalazine is indicated.
    [Abstract] [Full Text] [Related] [New Search]